ATLAS MOLECULAR PHARMA
Atlas Molecular Pharma is focused on the discovery of first-in-class, innovative therapeutics for the treatment of patients suffering from Rare and Ultra-Rare Diseases. Its line of work focuses on the development of a proprietary technology that enables the identification of molecules / drugs that provide stability to certain proteins whose dysfunction is responsible for the development of a large part of these rare diseases.
ATLAS MOLECULAR PHARMA
Industry:
Biotechnology Life Science Pharmaceutical Therapeutics
Founded:
2015-01-01
Address:
Derio, Pais Vasco, Spain
Country:
Spain
Website Url:
http://www.atlasmolecularpharma.com
Total Employee:
1+
Status:
Active
Contact:
+34 944061300
Email Addresses:
[email protected]
Total Funding:
3 M EUR
Technology used in webpage:
Euro Hetzner
Similar Organizations
Arctic Therapeutics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.
Bright Peak Therapeutics
Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Imvax
Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.
Iroko Pharmaceuticals
Iroko Pharmaceuticals is a global specialty pharmaceutical company dedicated to advancing the science of analgesia.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
VintaBio
VintaBio is a life sciences company that offers cell and gene therapy manufacturing services.
Current Employees Featured
Founder
Investors List
Ezten Venture Capital Fund
Ezten Venture Capital Fund investment in Venture Round - Atlas Molecular Pharma
Inveready
Inveready investment in Venture Round - Atlas Molecular Pharma
CDTI
CDTI investment in Venture Round - Atlas Molecular Pharma
Kereon Partners
Kereon Partners investment in Seed Round - Atlas Molecular Pharma
Official Site Inspections
http://www.atlasmolecularpharma.com
- Host name: www585.your-server.de
- IP address: 162.55.254.24
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Atlas Molecular Pharma"
About us - Atlas Molecular Pharma
Innovation and effectiveness for the treatment of rare and ultra-rare diseases. Background Atlas Molecular Pharma was founded in Biscay (Spain) in September 2015 as a spin-off company of …See details»
Atlas Molecular Pharma - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +34 944061300 Atlas Molecular Pharma is focused on the discovery of first-in-class, innovative therapeutics for the treatment …See details»
Atlas Molecular Pharma Profile and History - Datanyze
Www.atlasmolecularpharma.com . Atlas Molecular Pharma Profile and History. Atlas Molecular Pharma is focused on the discovery of first-in-class, innovative therapeutics for the treatment …See details»
Atlas Molecular Pharma Overview | SignalHire Company Profile
Organization Website: atlasmolecularpharma.com : Social Links: Phone Number +34 944061300: Atlas Molecular Pharma industries Pharma: Headquarters Location: Parque Cientifico …See details»
Atlas Molecular Pharma | VentureRadar
Website: https://atlasmolecularpharma.com/ Develops innovative therapeutics for rare and ultra-rare diseases using a proprietary technological platform, then licenses ...See details»
Investors - Atlas Molecular Pharma
Parque Tecnológico de Bizkaia Edificio 800, 48160 Derio (Bizkaia) [email protected] +34 944061300 (ext. 4338)See details»
ATLAS MOLECULAR PHARMA SOCIEDAD LIMITADA. Company …
Find company research, competitor information, contact details & financial data for ATLAS MOLECULAR PHARMA SOCIEDAD LIMITADA. of DERIO. Get the latest business insights …See details»
Atlas Molecular Pharma - Company Profile & Staff Directory
Atlas Molecular Pharma is focused on the discovery of first-in-class, innovative therapeutics for the treatment of patients suffering from Rare and Ultra-Rare Diseases.See details»
Atlas Molecular Pharma - Craft
Atlas Molecular Pharma is a company that develops therapeutics to treat rare and ultra-rare diseases. Its technology identifies multiple potential pharmacological chaperones (new …See details»
Atlas Molecular Pharma - Overview, News & Similar companies
View Atlas Molecular Pharma (www.atlasmolecularpharma.com) location in Basque Country, Spain , revenue, industry and description. Find related and similar companies as well as …See details»
Atlas Molecular Pharma - Company Profile - Tracxn
Sep 4, 2024 Atlas Molecular Pharma - Develops proprietary drug discovery platform. Raised a total funding of $3.4M over 2 rounds from 3 investors. Atlas Molecular Pharma has 2769 …See details»
Atlas Molecular Pharma - Products, Competitors, Financials, …
Headquarters Location. Parque Tecnológico de Bizkaia – Edificio 800 . Derio, 48160, Spain +34 944061300See details»
Atlas Molecular Pharma Company Information - Funding, …
Https://atlasmolecularpharma.com. Platform for discovering new, innovative treatments to help patients. GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY …See details»
Atlas Molecular Pharma - VentureRadar
"Our business model is to discover first-in-class, innovative therapeutics for the treatment of Rare and Ultra-Rare Diseases and license them to larger partners who will deliver them to market …See details»
People - Atlas Molecular Pharma
Oscar Millet (CEO) Oscar is doctor in organic chemistry and chemical engineer. He currently is the Group Leader at the Precision Medicine and Metabolism Laboratory of the CIC bioGUNE, …See details»
Atlas Molecular Pharma - PitchBook
Jan 29, 2020 Atlas Molecular Pharma General Information Description. Developer of therapeutic drugs designed to treat rare diseases. The company's services specialize in the identification …See details»
Atlas Molecular Pharma (company) | Nordic 9
Atlasmolecularpharma.com . See something wrong or missing? Let us know. Offices: Derio. Industry: Biotech Health services Manufacturing. Business model: B2B. Atlas Molecular …See details»
Partners - Atlas Molecular Pharma
We believe your input will help us design a treatment that affects the key aspects of your disease, as well as providing significant insight and advocacy in interactions with Regulatory Authorities …See details»
Technology - Atlas Molecular Pharma
A rare disease affects only a small percentage of the population, the reason why they have been neglected for years. Yet, a common mechanism is shared by many: an inherited mutation that …See details»
Pipeline - Atlas Molecular Pharma
Congenital Erythropoietic Porphyria (CEP). ATL-001. Our lead project targets the autosomal recessive deficiency in the uroporphyrinogen III synthase (UROIIIS) enzyme in the haeme …See details»